share_log

BRIEF-Samsara Vision To Initiate A U.S. Pma Supplemental Study Of The Sing Imt™, A New-Generation Technology For Age-Related Macular Degeneration

reuters ·  Apr 21, 2022 05:06

April 20 (Reuters) - Samsara Vision Inc  SMSA.O :

* SAMSARA VISION TO INITIATE A U.S. PMA SUPPLEMENTAL STUDY OF THE SING IMT™, A NEW-GENERATION TECHNOLOGY FOR AGE-RELATED MACULAR DEGENERATION

* SAMSARA VISION - ANNOUNCED FDA APPROVAL TO INITIATE U.S.-BASED, PMA SUPPLEMENTAL STUDY

* SAMSARA VISION INC - CONCERTO TRIAL WILL INCLUDE UP TO TWENTY CLINICAL SITES ACROSS UNITED STATES

Source text for Eikon:  ID:nBw5JsrLja  Further company coverage:  SMSA.O

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment